Publications by authors named "Anna Scardigli"

Claim this Profile
P
Pediatric Tuberculosis Research and Development: Progress, Priorities and Funding Opportunities.
Lindsay McKenna, Ani Herna Sari, Sushant Mane, Anna Scardigli, Grania Brigden

Pathogens· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic burden of multidrug-resistant tuberculosis.
Jose A Caminero, Anna Scardigli

Int J Tuberc Lung Dis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bedaquiline: how better to use it.
Jose A Caminero, Alberto Piubello, Anna Scardigli, Giovanni Battista Migliori

Eur Respir J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.
Jose A Caminero, Alberto Piubello, Anna Scardigli, Giovanni Battista Migliori

Eur Respir J· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classifying new anti-tuberculosis drugs: rationale and future perspectives.
Simon Tiberi, Anna Scardigli, Rosella Centis, Lia D'Ambrosio, Marcela Muñoz-Torrico

Int J Infect Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investing in a novel shorter treatment regimen for multidrug-resistant tuberculosis: to be repeated.
Mohammed A Yassin, Ernesto Jaramillo, Eliud Wandwalo, Dennis Falzon, Anna Scardigli

Eur Respir J· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Tuberculosis in children. Challenges and opportunities].
Jose A Caminero, Anna Scardigli

An Pediatr (Barc)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives.
Adrian Rendon, Simon Tiberi, Anna Scardigli, Lia D'Ambrosio, Rosella Centis

J Thorac Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of ethionamide versus prothionamide: a systematic review.
Anna Scardigli, Jose A Caminero, Giovanni Sotgiu, Rosella Centis, Lia D'Ambrosio

Eur Respir J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple and practical measures to reduce tuberculosis transmission in public buildings.
Anna Scardigli, Jose A Caminero

Int J Tuberc Lung Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
Simon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Marcos Abdo Arbex, Anna Scardigli

Eur Respir J· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.
Simon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Marcos Abdo Arbex, Anna Scardigli

Clin Infect Dis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
Simon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, Lia D'Ambrosio, Valentina Alarcon Guizado, Anna Scardigli

Eur Respir J· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of antituberculosis drugs: a new proposal based on the most recent evidence.
Jose A Caminero, Anna Scardigli

Eur Respir J· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.
Christoph Lange, Ibrahim Abubakar, Jan-Willem C Alffenaar, Graham Bothamley, Jose A Caminero, Anna Scardigli

Eur Respir J· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TB diagnostic capacity in sub-Saharan African HIV care settings.
Suzue Saito, Andrea A Howard, Michael J A Reid, Batya Elul, Anna Scardigli

J Acquir Immune Defic Syndr· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis incidence at the Burundi-Rwanda border 15 years after the civil war.
Lorenzo Guglielmetti, Angelo Cazzadori, Anna Scardigli, Romina Valentinotti, Michela Conti

Clin Infect Dis· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the recommendation not to use rifampin plus pyrazinamide for latent tuberculosis treatment always imperative?
Angelo Cazzadori, Benedetta Allegranzi, Anna Scardigli, Flavio Favari, Ercole Concia

Chest· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staphylococcal sepsis delaying diagnosis and treatment of vertebral tuberculosis.
Iacopo Baussano, Angelo Cazzadori, Chiara Danzi, Anna Scardigli, Ercole Concia

Scand J Infect Dis· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis